Fai A. Alkathiri
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Formulation and Development of Spray-Dried Atorvastatin Nanoparticles for Potential Antifungal Applications.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: May 23, 2026
Burden and Impact of Drug Shortages in a Saudi Tertiary Hospital: A Single-Center Cross-Sectional Survey.
Journal: Healthcare (Basel, Switzerland)
Published: March 14, 2026
GLOBAL RESEARCH TRENDS IN MRI SAFETY AND PATIENT AWARENESS: A BIBLIOMETRIC ANALYSIS (2000-2025).
Journal: Georgian medical news
Published: February 13, 2026
Investigating Escherichia coli Colicin E9 immunity protein interactions with DNA gyrase of Pseudomonas aeruginosa: advanced computational approach for developing novel antimicrobial strategies.
Journal: Scientific reports
Published: February 06, 2026
Electrospun PVA Nanofibers Co-Loaded with Atorvastatin and Zinc Oxide for Antibacterial and In Vitro Wound Healing Applications.
Journal: Biomedicines
Published: January 21, 2026
How do senior pharmacy students at King Saud University perceive their pharmaceutical calculation skills and preparedness for clinical practice?
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: October 07, 2025
Stability Assessment of Furosemide Oral Suspension in Hospital Extemporaneous Preparations.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 07, 2025
Assessing the Antibacterial Potential and Biofilm Inhibition Capability of Atorvastatin-Loaded Nanostructured Lipid Carriers via Crystal Violet Assay.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 02, 2025
Exploring the repurposed role of solithromycin as an antivirulence agent against Staphylococcus aureus and its resistant variants.
Journal: Frontiers in microbiology
Published: December 06, 2024
Assessing pharmacokinetics and drug-drug interactions of the combination therapy of myelofibrosis with ruxolitinib and lenalidomide by a new eco-friendly HPLC method for their simultaneous determination in plasma.
Journal: Cancer chemotherapy and pharmacology
Published: July 10, 2024
Last Updated: 09/26/2026